Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Photodynamic Therapy Versus Topical Calcipotriol in Oral Leukoplakia
NCT07453472Phase 3Not yet recruiting
- Start
- Apr 2026
- Primary completion
- Oct 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tolonium chloride and AKP01 in oral leukoplakia (2 arms). Primary endpoint: Clinical response at 12 weeks. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
tolonium chlorideAKP01
03
Conditions
oral leukoplakia
Beyond the preview
Go deeper on NCT07453472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07453472.